BMI1 and acute myeloid leukemia: With respect to the BMI-1 inhibitor PTC596, ML-2, PL-21 and MOLM-16 cells had IC50 >1 μM, while the other AML cell lines were susceptible with IC50 in the range of 200–500 nM.